Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Arrowhead Pharmaceuticals (ARWR)

Arrowhead Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ARWR
DateTimeSourceHeadlineSymbolCompany
09/05/202421:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/05/202423:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
16/04/202414:00GlobeNewswire Inc.Turnstone Biologics Appoints William Waddill to its Board of DirectorsNASDAQ:ARWRArrowhead Pharmaceuticals Inc
08/03/202422:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/03/202422:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
27/02/202422:08Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/02/202421:13Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/02/202421:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARWRArrowhead Pharmaceuticals Inc
02/02/202422:25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
31/01/202421:57Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
26/01/202422:28Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ARWRArrowhead Pharmaceuticals Inc
17/01/202423:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
17/01/202422:22Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:ARWRArrowhead Pharmaceuticals Inc
16/01/202423:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
16/01/202423:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
16/01/202423:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
16/01/202423:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
12/01/202421:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
11/01/202421:48Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
11/01/202421:38Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
11/01/202421:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
11/01/202421:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
08/01/202422:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
08/01/202422:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
08/01/202422:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/01/202401:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
06/01/202400:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
05/01/202422:33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
05/01/202422:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
05/01/202421:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ARWRArrowhead Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:ARWR